Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current and emerging therapies in Becker muscular dystrophy (BMD).

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology - 1 Sept 2019

Angelini Corrado, Marozzo Roberta, Pegoraro Valentina

Abstract excerpt

Becker muscular dystrophy (BMD) has onset usually in childhood, frequently by 11 years. BMD can present in several ways such as waddling gait, exercise related cramps with or without myoglobinuria. Rarely cardiomyopathy might be the presenting feature. The evolution is variable. BMD is caused by dystrophin deficiency due to inframe deletions, mutations or duplications in dystrophin gene (Xp21.2) We review here...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Steroids
Share to Angiotensin-Converting Enzyme Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cardiomyopathies

Share to Cytokines

Share to Dystrophin

Share to Muscular Dystrophies

Share to Oxidative Stress

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 31788661
PMCID: PMC6859412

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current and emerging therapies in Becker muscular dystrophy (BMD).PMID 31788661Read ↗

Diagnosis and management of Becker muscular dystrophy: the French guidelines.Semantic proximity Read ↗

Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.Semantic proximity Read ↗

[Clinical practice guidelines for Duchenne muscular dystrophy].Semantic proximity Read ↗

An update on Becker muscular dystrophy.Semantic proximity Read ↗

Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy.Semantic proximity Read ↗

Natural history of Becker muscular dystrophy: a multicenter study of 225 patients.Semantic proximity Read ↗

The Muscular Dystrophies: From Genes to TherapiesSemantic proximity Read ↗

Emerging therapeutic strategies in muscular dystrophy: an updated review on pathogenesis and treatment advances.Semantic proximity Read ↗

Muscle disease.Semantic proximity Read ↗

Characteristics of Disease Progression and Genetic Correlation in Ambulatory Iranian Boys With Duchenne Muscular DystrophySemantic proximity Read ↗

Towards a Cure: Emerging Therapeutic Advances for DMD, LGMD, and GNEM- Insights from Pre-Clinical and Clinical ResearchSemantic proximity Read ↗

An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.